We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eco Animal Health Group Plc | LSE:EAH | London | Ordinary Share | GB0032036807 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 118.00 | 116.00 | 120.00 | 118.00 | 118.00 | 118.00 | 10,142 | 07:31:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chem,fertlizer Minrl Mng,nec | 85.31M | 1.01M | 0.0149 | 79.19 | 79.94M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/2/2008 18:16 | gerraway. Wish I had that much influence ;o) | m.t.glass | |
15/2/2008 16:40 | let me guess that was you driving the price down? | smelleroo | |
15/2/2008 16:31 | Very late plunge took it sharply down through that 140 level | m.t.glass | |
13/2/2008 10:23 | On its way down again.. unless it bounces at 140 | m.t.glass | |
04/2/2008 14:54 | there were a couple of moments just then were there was no-one on the offer! NICE! | smelleroo | |
04/2/2008 07:47 | Eco Animal Health says unit gets OK to market Ecoheart dog tablets in Japan LONDON (Thomson Financial) - ECO Animal Health Group PLC said its Eco Animal Health Limited unit has received authorisation to sell the Ecoheart brand of worm-treatment tablets for dogs in Japan. The company formerly known as Lawrence PLC said the launch, slated for early this month, will be its first entry into the companion-animal sector. The canine heartworm prevention market is one of the three key sectors in the companion-animal market in Japan and with an estimated worth in the region of 20 mln usd at the manufacturing level, the company said. Separately, Eco said it has appointed Cenkos Securities PLC as its nominated advisor and joint broker. TFN.newsdesk@thomson ran/kf1 | waldron | |
23/1/2008 08:52 | Whatever ;o) | m.t.glass | |
23/1/2008 08:45 | > mt glass.You are doing a great job for me.The more you depress the price the more I buy!!It will be interesting to see who benefits most over the long term with EAH.The intrinsic value of the company is many times the present mkt cap in an industry with very high barriers to entry..... and lets not forget the near 6% yield.Keep up the good work PLEASE. I like to think of myself as an investor not a gambler " placing bets" and because I tend to take a rather longterm view am presently running a 400 BAGGER.Yes a 400 bagger so if you wish to raise the stakes invite me to the table. | ltinvestor | |
22/1/2008 19:32 | I rotate my bets all the time, matt - banking gains and reopening replacement bets, a bit like shouting "BANK!" on Weakest Link. And at the same time I use those ins/outs to increase or decrease my overall stake. So yes, I have in effect closed some parts of my downbets on EAH - but reopened them as well ;o) | m.t.glass | |
22/1/2008 17:59 | Is that you closing M.T.Glass? | matt123d | |
22/1/2008 16:33 | Someone I know was cashing in his downbet this afternoon, and lifting the price in the process. Makes it a bit difficult to push down with that buyback happening ;o) | m.t.glass | |
22/1/2008 11:49 | ...come on guys please try a little harder! | ltinvestor | |
22/1/2008 10:34 | - and then it duly fell, with a bump :-o | m.t.glass | |
22/1/2008 09:48 | Two of the five MMs have moved their prices downwards a little - just before 9am. (MOST at 8:51am and MLSB at 8:57am). No visible impact yet on the headline price but midprice has dropped to 124.5p | m.t.glass | |
16/1/2008 11:12 | A few sellers about again this morning, slow progress but 100p does look achievable. | matt123d | |
16/1/2008 08:18 | mtg. you are not trying hard enough. | ltinvestor | |
15/1/2008 11:57 | Down another notch.. | m.t.glass | |
14/1/2008 18:12 | MTG. I would like to see the share price around £1.Please try a little bit harder. | ltinvestor | |
14/1/2008 15:39 | Nah - think I might hang around awhile yet smelleroo. Anyway, you told us you weren't interested in this stock any more ;o) Can't argue re SIL though - already banked a whopping gain this morning and sitting on more there. When a broker commences coverage with a price target of zero it would be rude not to take advantage :-o | m.t.glass | |
14/1/2008 14:25 | spread your wings m.t.glass and fly away. i think you will make more money shorting silverjet! Bye, bye or should I say sell, sell! | smelleroo | |
14/1/2008 14:09 | No mention of this company among those prospective acquisition targets.. | m.t.glass | |
14/1/2008 11:45 | RPT Bayer declines to comment on possible interest in Teva's animal health ops (repeating to amend typographical error in sixth paragraph) FRANKFURT (Thomson Financial) - A spokesman for Bayer AG declined to comment on whether the company may be interested in buying Teva Pharmaceutical Industries Ltd's animal health business, but affirmed the company is still interested "in principle in acquisitions that make sense," especially in the HealthCare segment. "We cannot comment on concrete considerations," the spokesman said. Teva earlier today said it is exploring strategic alternatives for its animal health business, including a possible divestiture. This decision follows the company's 2007 strategic review. Teva's unit IVX Animal Health, which it acquired in early 2006, makes both branded and generic products for pets and livestock, with a focus on substances that kill bacteria, viruses and parasites as well as anti-itch drugs and nutritional supplements. The unit is one of the leading suppliers in the US. In addition, Teva's units Novopharm and Abic make animal health products. Bayer's animal health division, which makes products for both pets and livestock, last year posted sales of 905 mln eur on the success of its Advantage flea-control medication for cats and dogs. The company has said it aims to achieve global leadership in the livestock and pet markets through both organic growth and acquisitions. "Animal Health regularly evaluates options for acquisitions or strategic alliances to supplement our existing product range," the company said in its last annual financial report. Another possible candidate to buy Teva's animal health business may be Boehringer Ingelheim GmbH, which generated annual sales of about 360 mln eur with animal healthcare in 2005, some analysts said. Boehringer was not immediately available for comment. The company makes medications for horses, cows, pigs, cats and dogs. Both Novartis AG and Roche Holdings AG, based in Switzerland, declined comment on whether they would be interested in acquiring from Teva the animal health business. But it is understood that neither pharma group deals in animal health. maria.sheahan@thomso mas/slj/mas/slj | ariane | |
11/1/2008 19:53 | i would turn my attention to the bank sectors again with the US about to report q4 results next week (ML already looking at $15bn writedown) and so the rumours of emergency funding/ sub-prime writedowns will return. plus anything housing/ consumer related that trades on a double multiple! Eco does not interest me anymore | smelleroo | |
11/1/2008 17:31 | ;o) How much of that fall did you bank? And how much further do you think it might go? | m.t.glass | |
11/1/2008 17:23 | this company use to be 400p under its previous name of lawrence! so you are right - anyone can point at a faller after its fallen! | smelleroo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions